New Report: Who Gets The Corona Vaccine First

Oct. 2 release National Academies Release Framework for Equitable Allocation of a COVID-19 Vaccine for Adoption by HHS, State, Tribal, Local, and Territorial Authorities. Discusses the phases in detail.

On Oct. 2, 2020, the US National Academies of Science, Engineering, and Medicine (NASEM) issued its recommendations. For lots more information see below. A podcast, press release, and an article discuss the recommendations on who Gets The Corona Vaccine First

The NASEM was asked to develop its allocation plan by both the US Centers for Disease Control and Prevention (CDC). This plan will set the US government’s COVID-19 vaccination plan, and the US National Institutes of Health (NIH), which is coordinating vaccine and treatment trials

This framework can also inform the decisions of other groups, such as the Advisory Committee on Immunization Practices.  In addition to the framework, the report includes recommendations for HHS.

FOR A MUCH LARGER IMAGE, RIGHT CLICK TO OPEN IN A NEW TAB.

Phase 1a covers approximately 5 percent of the population and includes front-line health workers
Phase 1b covers approximately 10 percent of the population and includes people of all ages with comorbid and underlying conditions

Phase 2 covers approximately 30 percent to 35 percent of the population and includes K-12 teachers and school staff
Phase 3 covers approximately 40 percent to 45 percent of the population, and includes young adults, children
Phase 4 covers everyone residing in the U.S. who did not have access to the vaccine in prior phases.

NOTE: This Oct. 2 report is an update of the previous Sept. 1 report, done by the same committee. Some of the phases are clarified. My previous post on this Sept. 1 Draft discussion.

Podcast (36 minutes) Recorded 10-2-20 Who Gets The Corona Vaccine First
Speaker: William H. Foege, MD, MPH, emeritus distinguished professor of International Health at the Rollins School of Public Health at Emory University, co- chaired the committee that authored the report and discusses its recommendations.

This podcast is very informative, understandable, and worth listening to. The speaker is an “insider” who was on the committee. Three of the topics discussed are:
– Who is in the phases and why.
– Ethical issues.
– Who was on the committee and how they came to a consensus in only two months.

Listen to podcast. Note: play button is under the blue image on the left.

Related article: Fairly Prioritizing Groups for Access to COVID-19 Vaccines 9-10-20 Discusses Prioritizing Access to COVID-19 Vaccines.

– First, prioritizing in-person health care workers and staff, as NAM (US National Academy of Medicine) and others suggest
– Second, prioritizing people engaged in essential high-risk activities, such as in-person education, childcare, and food supply work
– Third, the World Health Organization (WHO) and NAM suggest prioritizing individuals whose medical conditions increase their risk of poor COVID-19 outcomes if they become infected.

Understandable, published by JAMA (Journal of the American Medical Association) with good references Read article

Previous discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine”(with a similar, less detailed table of phases) released September 1

The report is meant to be a guide for more detailed prioritization plans. That work is being conducted by the Advisory Committee on Immunization Practices, an expert panel that does vaccination guidance for the CDC, and by state, local, and tribal health authorities, who must identify the actual people in their regions who fall into the priority groups. Click here to read my previous post

How is the final decision made on who is in the Vaccination Phases?

CDC’s  Advisory Committee on Immunization Practices (ACIP) Provides recommendations on the use of vaccines for effective control of vaccine-preventable diseases in the US civilian population on licensure by the Food and Drug Administration (FDA).

CDC sets the immunization schedules based on ACIP’s recommendations. Only one vaccine is planning on testing children 12 and older (Pfizer). The adult schedule is approved by the American Academy of Family Physicians, the American College of Obstetricians and Gynecologists, the American College of Physicians, and the American College of Nurse-Midwives. Source: CDC

My comment: It was not clear to me who makes the very difficult final decisions. Many people have different opinions on this.

Link to article with more information on AICP

My recommendation on what to read:

First, listen to the 36-minute podcast. The speaker is an “insider” who was on the committee and has decades of experience. Good speaker. Very understandable. Look at the table above for an overall view. Read the press release (with lots of information) or article if you want more information.

Please leave a comment. We want to know what you think!!